{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T08:54:41Z","timestamp":1781859281257,"version":"3.54.5"},"reference-count":41,"publisher":"BMJ","issue":"10","license":[{"start":{"date-parts":[[2020,10,13]],"date-time":"2020-10-13T00:00:00Z","timestamp":1602547200000},"content-version":"unspecified","delay-in-days":12,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010727","name":"Axel Muusfeldts Fond","doi-asserted-by":"publisher","award":["2018-1311"],"award-info":[{"award-number":["2018-1311"]}],"id":[{"id":"10.13039\/100010727","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006197","name":"Fonden til L\u00e6gevidenskabens Fremme","doi-asserted-by":"publisher","award":["18-L-0173"],"award-info":[{"award-number":["18-L-0173"]}],"id":[{"id":"10.13039\/501100006197","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2020,8,13]]},"published-print":{"date-parts":[[2020,10]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Recent studies in in vitro fertilisation (IVF) patients have associated abnormal vaginal microbiota (AVM) with poor clinical pregnancy rates of 6%\u20139% per embryo transfer. The biological plausibility for this finding is hypothesised to be ascending infection to the endometrium which in turn hampers embryo implantation. New molecular based diagnosis may offer advantages compared to microscopical diagnosis of AVM which has huge inter-study variability ranging from 4 to 38%; however, the important question is whether screening and treatment of AVM would improve reproductive outcomes in IVF patients. Herein, we describe a protocol for an ongoing double-blind, placebo-controlled multicentre trial of IVF patients diagnosed with AVM and randomised in three parallel groups 1:1:1.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>\n                      This is a drug intervention study where IVF patients will be screened for AVM, using a qPCR assay targeting\n                      <jats:italic>Atopobium vaginae<\/jats:italic>\n                      and\n                      <jats:italic>Gardnerella vaginalis<\/jats:italic>\n                      . If positive, patients will be randomised to one of the three study arms. The first arm consists of clindamycin 300 mg \u00d72 daily for 7 days followed by vaginal\n                      <jats:italic>Lactobacillus crispatus<\/jats:italic>\n                      CTV-05 until clinical pregnancy scan week 7\u20139. The second arm consists of clindamycin and placebo\n                      <jats:italic>L. crispatus<\/jats:italic>\n                      CTV-05, whereas patients in the third arm will be treated with placebo\/placebo. We used a superiority design to estimate that active treatment in both arms will increase the primary outcome, clinical pregnancy rate per embryo transfer, from 20% to 40%. A potential difference between the two active arms was considered exploratory. With a power of 80% and an alpha at 5%, the sample size is estimated to be 333 patients randomised. A pre-planned interim analysis is scheduled at 167 patients randomised.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>All patients have to give informed consent. Dissemination of results is ensured in clinical trial agreements whether they be positive or not. Ethics committee, Central Denmark Region approved this protocol.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>ICH-GCP monitored trial, EudraCT 2016-002385-31; Pre-results.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2019-035866","type":"journal-article","created":{"date-parts":[[2020,10,13]],"date-time":"2020-10-13T17:10:40Z","timestamp":1602609040000},"page":"e035866","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":10,"title":["Effect of clindamycin and a live biotherapeutic on the reproductive outcomes of IVF patients with abnormal vaginal microbiota: protocol for a double-blind, placebo-controlled multicentre trial"],"prefix":"10.1136","volume":"10","clinical-trial-number":[{"clinical-trial-number":"nct03420859","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9304-5299","authenticated-orcid":false,"given":"Thor","family":"Haahr","sequence":"first","affiliation":[{"name":"Department of Clinical Medicine, Aarhus Universitet, Aarhus, Denmark"},{"name":"The Fertility Clinic, Skive Regional Hospital, Skive, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina La Cour","family":"Freiesleben","sequence":"additional","affiliation":[{"name":"The Fertility Clinic, Hvidovre University Hospital, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Pinborg","sequence":"additional","affiliation":[{"name":"The Fertility Clinic, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henriette Svarre","family":"Nielsen","sequence":"additional","affiliation":[{"name":"The Fertility Clinic, Hvidovre University Hospital, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vibeke","family":"Hartvig","sequence":"additional","affiliation":[{"name":"Stork Fertility Clinic, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Lis","family":"Mikkelsen","sequence":"additional","affiliation":[{"name":"The Fertility Clinic, Sj\u00e6llands Universitetshospital K\u00f8ge, Koge, Sjaelland, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Parks","sequence":"additional","affiliation":[{"name":"Osel Inc, Mountain View, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels","family":"Uldbjerg","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Aarhus Universitet, Aarhus, Denmark"},{"name":"Department of Obstetrics and Gynecology, Aarhus Universitetshospital, Aarhus, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7464-7435","authenticated-orcid":false,"given":"J\u00f8rgen Skov","family":"Jensen","sequence":"additional","affiliation":[{"name":"Department of Reproductive Microbiology, Statens Serum Institute, Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6884-5366","authenticated-orcid":false,"given":"Peter","family":"Humaidan","sequence":"additional","affiliation":[{"name":"Department of Clinical Medicine, Aarhus Universitet, Aarhus, Denmark"},{"name":"The Fertility Clinic, Skive Regional Hospital, Skive, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2020,10,13]]},"reference":[{"key":"2025120523360093000_10.10.e035866.1","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0b013e318074e565"},{"key":"2025120523360093000_10.10.e035866.2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1002611107"},{"key":"2025120523360093000_10.10.e035866.3","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-019-0465-8"},{"key":"2025120523360093000_10.10.e035866.4","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.15178"},{"key":"2025120523360093000_10.10.e035866.5","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dew026"},{"key":"2025120523360093000_10.10.e035866.6","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dez065"},{"key":"2025120523360093000_10.10.e035866.7","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.29.2.297-301.1991"},{"key":"2025120523360093000_10.10.e035866.8","doi-asserted-by":"publisher","DOI":"10.1177\/0956462418785451"},{"key":"2025120523360093000_10.10.e035866.9","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1016\/S0140-6736(18)31617-9","article-title":"Early clindamycin for bacterial vaginosis in pregnancy (PREMEVA): a multicentre, double-blind, randomised controlled trial","volume":"392","author":"Subtil","year":"2018","journal-title":"Lancet"},{"key":"2025120523360093000_10.10.e035866.10","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/aogs.12933","article-title":"Treatment of bacterial vaginosis in pregnancy in order to reduce the risk of spontaneous preterm delivery \u2013 a clinical recommendation","volume":"95","author":"Haahr","year":"2016","journal-title":"Acta Obstet Gynecol Scand"},{"key":"2025120523360093000_10.10.e035866.11","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0b013e3181e50026"},{"key":"2025120523360093000_10.10.e035866.12","unstructured":"U.S. Department of Health and Human Services . Early clinical trials with live biotherapeutic products: chemistry, manufacturing, and control information; guidance for industry, 2012."},{"key":"2025120523360093000_10.10.e035866.13","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1093\/infdis\/jiy744","article-title":"Vaginal microbiota and in vitro fertilization outcomes: development of a simple diagnostic tool to predict patients at risk of a poor reproductive outcome","volume":"219","author":"Haahr","year":"2019","journal-title":"J Infect Dis"},{"key":"2025120523360093000_10.10.e035866.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2016.09.075"},{"key":"2025120523360093000_10.10.e035866.15","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/rmb2.12250","article-title":"A pilot study and case reports on endometrial microbiota and pregnancy outcome: an analysis using 16S rRNA gene sequencing among IVF patients, and trial therapeutic intervention for dysbiotic endometrium","volume":"18","author":"Kyono","year":"2019","journal-title":"Reprod Med Biol"},{"key":"2025120523360093000_10.10.e035866.16","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.fertnstert.2019.05.015","article-title":"Endometrial microbiota in infertile women with and without chronic endometritis as diagnosed using a quantitative and reference range-based method","volume":"112","author":"Liu","year":"2019","journal-title":"Fertil Steril"},{"key":"2025120523360093000_10.10.e035866.17","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.rbmo.2018.12.019","article-title":"Vaginal microbiota profile at the time of embryo transfer does not affect live birth rate in IVF cycles with donated oocytes","volume":"38","author":"Vergaro","year":"2019","journal-title":"Reprod Biomed Online"},{"key":"2025120523360093000_10.10.e035866.18","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-46173-0"},{"key":"2025120523360093000_10.10.e035866.19","doi-asserted-by":"crossref","DOI":"10.1186\/s12941-020-00385-9","article-title":"Low biomass microbiota in the upper genital tract of reproductive age women: fact or fiction?","volume":"19","author":"Haahr","year":"2020","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"2025120523360093000_10.10.e035866.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2014.11.043"},{"key":"2025120523360093000_10.10.e035866.21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0053997"},{"key":"2025120523360093000_10.10.e035866.22","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1016\/j.rbmo.2019.04.006","article-title":"Vaginal microbiota and IVF outcomes: poor diagnosis results in flawed conclusions","volume":"39","author":"Haahr","year":"2019","journal-title":"Reprod Biomed Online"},{"key":"2025120523360093000_10.10.e035866.23","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1093\/humrep\/dez167","article-title":"Non-transparent and insufficient descriptions of non-validated microbiome methods and related reproductive outcome results should be interpreted with caution","volume":"34","author":"Haahr","year":"2019","journal-title":"Hum Reprod"},{"key":"2025120523360093000_10.10.e035866.24","doi-asserted-by":"publisher","DOI":"10.1038\/nature24460"},{"key":"2025120523360093000_10.10.e035866.25","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.anaerobe.2019.02.005","article-title":"Susceptibility of endometrial isolates recovered from women with clinical pelvic inflammatory disease or histological endometritis to antimicrobial agents","volume":"56","author":"Petrina","year":"2019","journal-title":"Anaerobe"},{"key":"2025120523360093000_10.10.e035866.26","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/j.1471-0528.1977.tb12516.x","article-title":"Pelvic tissue and serum concentrations of various antibiotics given as pre-operative medication","volume":"84","author":"Elder","year":"1977","journal-title":"Br J Obstet Gynaecol"},{"key":"2025120523360093000_10.10.e035866.27","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiv079"},{"key":"2025120523360093000_10.10.e035866.28","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172660","article-title":"Probiotics for the treatment of women with bacterial vaginosis: a systematic review and meta-analysis of randomized clinical trials","volume":"864","author":"Li","year":"2019","journal-title":"Eur J Pharmacol"},{"key":"2025120523360093000_10.10.e035866.29","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/1471-0528.15870","article-title":"Lactobacilli-containing vaginal probiotics to cure or prevent bacterial or fungal vaginal dysbiosis: a systematic review and recommendations for future trial designs","volume":"127","author":"van de Wijgert","year":"2020","journal-title":"BJOG"},{"key":"2025120523360093000_10.10.e035866.30","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/1471-0528.15910","article-title":"The need for better evidence to support probiotics for vaginitis","volume":"127","author":"Hillier","year":"2020","journal-title":"BJOG"},{"key":"2025120523360093000_10.10.e035866.31","first-page":"72","article-title":"The impact of progesterone on the vaginal microbiome in high-risk pregnancy with a short cervix","volume":"123","author":"Kindinger","year":"2016","journal-title":"BJOG Int J Obstet Gynaecol"},{"key":"2025120523360093000_10.10.e035866.32","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/1471-0528.15299","article-title":"Vaginal microbiome in early pregnancy and subsequent risk of spontaneous preterm birth: a case\u2013control study","volume":"126","author":"Tabatabaei","year":"2019","journal-title":"BJOG"},{"key":"2025120523360093000_10.10.e035866.33","doi-asserted-by":"publisher","DOI":"10.1111\/1471-0528.15854"},{"key":"2025120523360093000_10.10.e035866.34","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00460-13","article-title":"Influence of vaginal bacteria and D- and L-lactic acid isomers on vaginal extracellular matrix metalloproteinase inducer: implications for protection against upper genital tract infections","volume":"4","author":"Witkin","year":"2013","journal-title":"mBio"},{"key":"2025120523360093000_10.10.e035866.35","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01548-19","article-title":"The cervicovaginal microbiota-host interaction modulates Chlamydia trachomatis infection","volume":"10","author":"Edwards","year":"2019","journal-title":"mBio"},{"key":"2025120523360093000_10.10.e035866.36","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1056\/NEJMoa1915254","article-title":"Randomized trial of Lactin-V to prevent recurrence of bacterial vaginosis","volume":"382","author":"Cohen","year":"2020","journal-title":"N Engl J Med"},{"key":"2025120523360093000_10.10.e035866.37","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cir183"},{"key":"2025120523360093000_10.10.e035866.38","doi-asserted-by":"publisher","DOI":"10.1093\/epirev\/24.1.39"},{"key":"2025120523360093000_10.10.e035866.39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2008.08.010"},{"key":"2025120523360093000_10.10.e035866.40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2019.103208"},{"key":"2025120523360093000_10.10.e035866.41","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.d40"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2019-035866","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,6]],"date-time":"2025-12-06T07:36:10Z","timestamp":1765006570000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2019-035866"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":41,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2020,10,13]]},"published-print":{"date-parts":[[2020,10]]}},"alternative-id":["10.1136\/bmjopen-2019-035866"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2019-035866","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10]]}}}